Physician profile
Natacha Smith
NPI 1003298035
$3,469.68
in general payments reported to CMS, 2019-2025
17 companies · $1,055 in 2025
The $1,055 reported for 2025 was more than what 81% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,253 · 2022: $165 · 2023: $175 · 2024: $822 · 2025: $1,055.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,003 · Education: $48.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,002.78 |
| Education | $48.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $715.19 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $588.01 | 2021-2025 | Rexulti, Abilify Asimtufii, Abilify Maintena |
| Supernus Pharmaceuticals, INC. | $456.55 | 2024-2025 | Qelbree |
| Vanda Pharmaceuticals INC. | $419.99 | 2021-2025 | Fanapt |
| Lundbeck LLC | $207.31 | 2021-2025 | Abilify Asimtufii, Abilify Maintena, Brintellix |
| Janssen Pharmaceuticals, INC | $204.71 | 2021-2025 | Spravato, Invega Sustenna |
| Abbvie INC. | $189.88 | 2021-2025 | |
| Neurocrine Biosciences, INC. | $178.05 | 2021-2025 | Ingrezza |
| Teva Pharmaceuticals USA, INC. | $133.98 | 2021-2025 | Uzedy, Austedo, Austedo Xr |
| Takeda Pharmaceuticals U.S.A., INC. | $128.66 | 2021 | |
| Sunovion Pharmaceuticals INC. | $110.58 | 2021 | |
| Axsome Therapeutics, INC. | $49.61 | 2025 | Auvelity |
| Allergan, INC. | $22.90 | 2021 | |
| Ironshore Pharmaceuticals INC. | $17.26 | 2023 | Jornay Pm |
| Adlon Therapeutics L.P. | $16.64 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| B. Braun Interventional Systems INC. | $16.32 | 2021 | |
| Owp Pharmaceuticals, INC. | $14.04 | 2025 | Subvenite |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natacha Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.